| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |